How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective
The 80 statements underlined the complex and manifold nature of the CAR-T treatment process. Our results reflect the first step in overcoming hurdles: identifying potential hurdles and required preconditions. Decision-makers and stakeholders can use the results to derive strategies and measures to further promote a frictionless process.
Authors
- Florian Kron (ORCID: https://orcid.org/0000-0003-4907-7490)
- Christof Scheid (ORCID: https://orcid.org/0009-0007-6539-226X)
- Melina Sophie Kurte (ORCID: https://orcid.org/0009-0006-8918-1769)
- Hans Christian Reinhardt (ORCID: https://orcid.org/0000-0001-5706-9349)
- Marcel Teichert
- Bastian von Tresckow (ORCID: https://orcid.org/0000-0003-1410-4487)
- Florian Jakobs (ORCID: https://orcid.org/0009-0002-1548-4610)
- Ann‐Cathrine Siefen (ORCID: https://orcid.org/0009-0002-3246-1461)
- Mathias Hänel (ORCID: https://orcid.org/0000-0002-4767-3275)
- Udo Holtick
- Elisa Sala (ORCID: https://orcid.org/0000-0001-8603-3839)
- Christian Jehn
- Anke Warnecke
- Johannes Atta
Institutions
- University of Cologne (DE)
- Universitätsklinikum Gießen und Marburg (DE)
- FOM University of Applied Sciences for Economics and Management (DE)
- Universitätsmedizin Göttingen (DE)
- Essen University Hospital (DE)
- Asklepios Klinik St. Georg (DE)
- QUIRIS Healthcare (DE)
- University Hospital Cologne (DE)
- University Hospital Ulm (DE)
- West German Heart and Vascular Center Essen (DE)
- Klinikum Chemnitz (DE)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.3389/fonc.2024.1466803
- Citations
- 4
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Gilead Sciences